Kenya AA, Re: The company today mapped out a long list of potential uses for Enbrel, including psoriasis, psoriatic arthritis, congestive heart failure, hepatitis C, Crohn's disease and diabetes. The company is in various stages of human and animal studies for these potential uses.
With additional approval of Enbrel for use in a number of these conditions, annual sales could exceed $6 billion, rivaling the world's top-selling prescription drug Prilosec, the company said. Prilosec, made by AstraZeneca Group Plc, had sales of $5.9 billion last year.
I wonder whether we could dig out some more information on the above statement. As I understand Bloomberg does refer to some company information.
Do you have any link?
Regards,
Manfred |
